Bharat Biotech says Covid-19 vaccine shows 81% interim efficacy, Health News, ET HealthWorld

0
37


Indian firm Bharat Biotech‘s homegrown Covid-19 vaccine has shown an interim vaccine efficacy of 81% in late-stage clinical trials, the company said on Wednesday.

The trials involved 25,800 participants and was conducted in partnership with the Indian government’s medical research body.

Follow and connect with us on , Facebook, Linkedin



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here